UNSPSC 85621202: Repair paraganglion extremity, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to repair paraganglion extremity, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0GQF3ZZ

UNSPSC 85621202 Repair paraganglion extremity, percutaneous approach is a Commodity code with significant disconnect between its nominal scope and the state and local procurement activity actually tagged under it. The recent opportunities posted under this code show no alignment with surgical or medical repair of paragangliomas or similar neuroendocrine pathology; instead, the solicitations cover inmate medical and pharmacy services, pharmacy benefit management, virtual primary care, peer support services, and fire department medical direction—none involving the specialized interventional procedure the code name denotes. The code does not reflect procurement of surgical paraganglion repair services or the medical devices, staff, or facility support such procedures would require.

The geographic spread of activity is limited to Florida and Georgia, with opportunities from Muscogee County (Columbus) Georgia, Collier County Florida, Monroe County Florida, and fire department services in California; activity outside these jurisdictions is not supported by the source. The mix of issuing bodies includes county government procurement divisions and county health authorities; school districts, transit authorities, and special-purpose districts do not appear in the recent postings. Representative recent opportunities include Columbus Consolidated Government's RFP No. 26-0008 for inmate medical and pharmacy services (RFP due May 15, 2026, current monthly cost $95,537.71 under incumbent CorrectHealth Companies LLC) and Collier County Board of County Commissioners' RFP 25-8414 for pharmacy benefit management services covering approximately 2,400 employees and 4,800 covered members with historical annual pharmacy spending of $8.7 million (RFP due April 9, 2026). The code shows little relevant recent activity and the mismatch between the code's surgical scope and the health services procurement actually occurring under it suggests misclassification at the point of posting rather than active market activity in paraganglion repair contracting.